Bioactive compounds and probiotics-a ray of hope in COVID-19 management

The use of bioactive compounds and probiotic bacteria against the viral diseases in human is known for a long time. Anti -viral, anti-inflammatory and anti-allergic properties of bioactive compounds and bacteria with probiotic properties in respiratory viral diseases may have significance to enhance immunity. This review highlights some of the important bioactive compounds and probiotic bacteria, suggesting them as a ray of hope in the milieu of the COVID-19 management. (C) 2021 Beijing Academy of Food Sciences. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.

Automated summary

Bioactive compounds and probiotic bacteria have anti-viral, anti-inflammatory, and anti-allergic properties in respiratory viral diseases, which may help enhance immunity. They are suggested as a ray of hope in COVID-19 management.